Neurogenetic analysis of childhood disintegrative disorder
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Childhood disintegrative disorder (CDD) is a rare form of autism spectrum disorder (ASD) of unknown etiology. It is characterized by late-onset regression leading to significant intellectual disability (ID) and severe autism. Although there are phenotypic differences between CDD and other forms of ASD, it is unclear if there are neurobiological differences. We pursued a multidisciplinary study of CDD ( n = 17) and three comparison groups: low-functioning ASD ( n = 12), high-functioning ASD ( n = 50), and typically developing ( n = 26) individuals. We performed whole-exome sequencing (WES), copy number variant (CNV), and gene expression analyses of CDD and, on subsets of each cohort, non-sedated functional magnetic resonance imaging (fMRI) while viewing socioemotional (faces) and non-socioemotional (houses) stimuli and eye tracking while viewing emotional faces. We observed potential differences between CDD and other forms of ASD. WES and CNV analyses identified one or more rare de novo, homozygous, and/or hemizygous (mother-to-son transmission on chrX) variants for most probands that were not shared by unaffected sibling controls. There were no clearly deleterious variants or highly recurrent candidate genes. Candidate genes that were found to be most conserved at variant position and most intolerant of variation, such as TRRAP , ZNF236 , and KIAA2018 , play a role or may be involved in transcription. Using the human BrainSpan transcriptome dataset, CDD candidate genes were found to be more highly expressed in non-neocortical regions than neocortical regions. This expression profile was similar to that of an independent cohort of ASD probands with regression. The non-neocortical regions overlapped with those identified by fMRI as abnormally hyperactive in response to viewing faces, such as the thalamus, cerebellum, caudate, and hippocampus. Eye-tracking analysis showed that, among individuals with ASD, subjects with CDD focused on eyes the most when shown pictures of faces. Given that cohort sizes were limited by the rarity of CDD, and the challenges of conducting non-sedated fMRI and eye tracking in subjects with ASD and significant ID, this is an exploratory study designed to investigate the neurobiological features of CDD. In addition to reporting the first multimodal analysis of CDD, a combination of fMRI and eye-tracking analyses are being presented for the first time for low-functioning individuals with ASD. Our results suggest differences between CDD and other forms of ASD on the neurobiological as well as clinical level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lord, C., Elsabbagh, M., Baird, G., & Veenstra-Vanderweele, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31129-2 · Cited by 2,819
Self-citationThe contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · cited 1×
“Given this observation, we compared the difference in median expression levels between non-neocortical and neocortical regions for genes affected by nonsynonymous and synonymous variants in CDD probands, their unaffected siblings, and ASD probands from the Simons Simplex Collection (SSC) with and without regression [2…”
BackgroundSelf-citationKlin, A., Jones, W., Schultz, R., Volkmar, F., & Cohen, D. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.809 · Cited by 2,120
Self-citationSpatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084 · cited 5×
“Log2-transformed signal intensity≥ 6 in at least one sample is considered positive expression [20].”
BackgroundMethodInfluentialEpidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“While the prevalence of ASD is reported to be 1/68 [18], the prevalence of CDD is estimated to be 1–2/100,000 [19].”
BackgroundDe novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci
Sanders, S. J., He, X., Willsey, A. J., Ercan-Sencicek, A. G., Samocha, K. E., Cicek, A. E., Murtha, M. T., Bal, V. H., Bishop, S. L., Dong, S., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.016 · Cited by 1,430
Self-citationAttention to eyes is present but in decline in 2–6-month-old infants later diagnosed with autism
Jones, W., & Klin, A. (2013) · Nature · doi:10.1038/nature12715 · Cited by 1,293
Cited by
Big data approaches to decomposing heterogeneity across the autism spectrum
Lombardo, M. V., Lai, M.-C., & Baron-Cohen, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0321-0 · Cited by 537
Ozonoff, S., & Iosif, A.-M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.012 · Cited by 146
Boterberg, S., Charman, T., Marschik, P. B., Bölte, S., & Roeyers, H. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.013 · Cited by 77
Pearson, N., Charman, T., Happé, F., Bolton, P. F., & McEwen, F. S. (2018) · Autism Research · doi:10.1002/aur.2035 · Cited by 75
“The expression profile of candidate genes for CDD resembles that of individuals from simplex families who have autism with regression, but not that of individuals without regression [Gupta et al., 2017], suggesting that de novo genetic mutations may play a role in regression.”
Background
Metadata
- Authors
- Gupta, A. R., Westphal, A., Yang, D. Y. J., Sullivan, C. A. W., Eilbott, J., Zaidi, S., Voos, A., Vander Wyk, B. C., Ventola, P., Waqar, Z., Fernandez, T. V., Ercan-Sencicek, A. G., Walker, M. F., Choi, M., Schneider, A., Hedderly, T., Baird, G., Friedman, H., Cordeaux, C., Ristow, A., Shic, F., Volkmar, F. R., & Pelphrey, K. A.
- Venue
- Molecular Autism
- Published
- 2017-04-04
- Volume
- 8
- Issue
- 1
- Pages
- 19-19
- ISSN
- 2040-2392 (ISSN-L)
- OpenAlex
- W2605178931
- Cited by
- 27
- References
- 24
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurogenetic analysis of childhood disintegrative disorder. https://app.cochat.ai/papers/10.1186/s13229-017-0133-0
- The paper
- Gupta, A. R., Westphal, A., Yang, D. Y. J., Sullivan, C. A. W., Eilbott, J., Zaidi, S., Voos, A., Vander Wyk, B. C., Ventola, P., Waqar, Z., Fernandez, T. V., Ercan-Sencicek, A. G., Walker, M. F., Choi, M., Schneider, A., Hedderly, T., Baird, G., Friedman, H., Cordeaux, C., . . . Pelphrey, K. A. (2017). Neurogenetic analysis of childhood disintegrative disorder. Molecular Autism. https://doi.org/10.1186/s13229-017-0133-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.